Bilcare Boosts Caprihans Stake, Completes UK Subsidiary Exit

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Bilcare Boosts Caprihans Stake, Completes UK Subsidiary Exit
Overview

Bilcare Limited has finished major company changes, boosting its stake in Caprihans India Limited by converting warrants. The company also successfully closed its UK subsidiary, Bilcare GCS Limited, to simplify operations. This increased shareholding in Caprihans shows Bilcare's ongoing focus on the packaging solutions firm.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Bilcare Boosts Caprihans Stake, Completes UK Unit Exit

₹3.15 crore in preference shares redeemed; UK subsidiary posted ₹11.88 lakh turnover.

What happened today

Bilcare Limited's Board of Directors reviewed key corporate actions on March 30, 2026. On March 23, 2026, the company redeemed 31,50,000 preference shares in Caprihans India Limited for ₹3.15 crore. Between March 20-25, 2026, Bilcare converted 12,90,000 warrants into equity shares of Caprihans India Limited, raising its stake. The voluntary liquidation of Bilcare GCS Limited, its wholly-owned UK subsidiary, has also been finalized.

Why it matters

The increased stake in Caprihans India Limited highlights Bilcare's ongoing strategic interest and influence in its packaging solutions associate. The successful closure of Bilcare GCS Limited, a minor subsidiary with a turnover of ₹11.88 lakh, simplifies the group's structure and cuts administrative costs.

Company Background

Bilcare acquired Caprihans India Limited in 2010 as part of the INEOS Films business purchase. Bilcare Limited previously underwent a corporate insolvency resolution process, entering NCLT proceedings in 2019. In a 2023 settlement, Caprihans India Limited used its balance sheet to buy Bilcare's operating assets, helping Bilcare pay its lenders. Bilcare has continued to acquire stakes in Caprihans, with recent purchases in January 2025 and March 2026, pointing to an ongoing consolidation of ownership.

Changes Now

Bilcare Limited's ownership in Caprihans India Limited has grown following the warrant conversions. Bilcare GCS Limited is no longer a subsidiary of Bilcare Limited after its liquidation concluded.

Key Risks

Liquidation proceeds of GBP 195,781.83 from Bilcare GCS Limited have been sent but are still awaiting credit to Bilcare Limited's account. Past regulatory actions, such as an ₹11 lakh penalty by SEBI in May 2024 for reporting violations and an NFRA debarment of an auditor over misstated financials (FY14-15 to FY16-17), point to previous governance and compliance issues.

Industry Peers

Bilcare and its associate Caprihans work in the packaging films sector. Key competitors include EPL Limited, Uflex Limited, and Cosmo First Limited, which also focus on flexible and specialty films for industries like pharmaceuticals.

What to watch for

Confirmation that liquidation proceeds have credited Bilcare Limited's account. Updates on SEBI regulatory compliance concerning the subsidiary liquidation. Future strategic moves and performance from Caprihans India Limited, especially after Bilcare's larger stake.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.